Han‐Mo Yang

4.1k total citations · 1 hit paper
106 papers, 2.6k citations indexed

About

Han‐Mo Yang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Han‐Mo Yang has authored 106 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Cardiology and Cardiovascular Medicine, 54 papers in Surgery and 27 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Han‐Mo Yang's work include Coronary Interventions and Diagnostics (45 papers), Antiplatelet Therapy and Cardiovascular Diseases (28 papers) and Cardiac Imaging and Diagnostics (27 papers). Han‐Mo Yang is often cited by papers focused on Coronary Interventions and Diagnostics (45 papers), Antiplatelet Therapy and Cardiovascular Diseases (28 papers) and Cardiac Imaging and Diagnostics (27 papers). Han‐Mo Yang collaborates with scholars based in South Korea, United States and Puerto Rico. Han‐Mo Yang's co-authors include Kyung Woo Park, Hyun‐Jae Kang, Hyo‐Soo Kim, Bon‐Kwon Koo, Jung‐Kyu Han, Byung‐Hee Oh, Young-Bae Park, Jeehoon Kang, Hae‐Young Lee and Ju‐Young Kim and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Han‐Mo Yang

100 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial Dysfunction in Cardiovascular Diseases

2025 16 citations Han‐Mo Yang profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han‐Mo Yang South Korea	28	1.1k	1.1k	533	508	302	106	2.6k
Soon Jun Hong South Korea	30	1.2k 1.1×	1.3k 1.2×	519 1.0×	312 0.6×	255 0.8×	188	2.8k
Seiji Hokimoto Japan	30	988 0.9×	1.8k 1.6×	321 0.6×	701 1.4×	431 1.4×	166	3.1k
Kiyuk Chang South Korea	28	989 0.9×	1.6k 1.5×	492 0.9×	602 1.2×	245 0.8×	222	2.9k
Alberto Balbarini Italy	29	567 0.5×	1.1k 1.0×	477 0.9×	309 0.6×	369 1.2×	112	2.4k
Neil Ruparelia United Kingdom	23	742 0.7×	943 0.9×	417 0.8×	348 0.7×	329 1.1×	109	2.2k
Yongjian Wu China	29	1.2k 1.1×	1.4k 1.3×	389 0.7×	759 1.5×	549 1.8×	265	3.1k
Bum‐Kee Hong South Korea	28	1.8k 1.6×	1.6k 1.5×	375 0.7×	818 1.6×	416 1.4×	126	3.3k
Atsushi Tanaka Japan	22	712 0.6×	917 0.8×	503 0.9×	484 1.0×	291 1.0×	119	2.3k
Sang Hong Baek South Korea	30	780 0.7×	1.9k 1.7×	568 1.1×	398 0.8×	348 1.2×	184	3.4k
Jean‐François Tanguay Canada	35	1.8k 1.6×	2.9k 2.7×	664 1.2×	515 1.0×	490 1.6×	166	4.5k

Countries citing papers authored by Han‐Mo Yang

Since Specialization

Citations

This map shows the geographic impact of Han‐Mo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Mo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Mo Yang more than expected).

Fields of papers citing papers by Han‐Mo Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Mo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Mo Yang. The network helps show where Han‐Mo Yang may publish in the future.

Co-authorship network of co-authors of Han‐Mo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Mo Yang. A scholar is included among the top collaborators of Han‐Mo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Mo Yang. Han‐Mo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Han‐Mo. (2025). GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies. Journal of Clinical Medicine. 14(19). 6758–6758. 2 indexed citations

Yang, Han‐Mo. (2025). Overcoming the Blood–Brain Barrier: Advanced Strategies in Targeted Drug Delivery for Neurodegenerative Diseases. Pharmaceutics. 17(8). 1041–1041. 3 indexed citations

Yang, Han‐Mo. (2025). Mitochondrial Dysfunction in Neurodegenerative Diseases. Cells. 14(4). 276–276. 16 indexed citations

Kang, Jeehoon, Kyung Woo Park, Bon‐Kwon Koo, et al.. (2024). Clopidogrel Versus Aspirin as Chronic Maintenance Antiplatelet Monotherapy in Patients After Percutaneous Coronary Intervention With Chronic Kidney Disease: A Post Hoc Analysis of the HOST‐EXAM Trial. Journal of the American Heart Association. 13(18). e035269–e035269. 1 indexed citations

Shin, Eun‐Seok, Eun Jung Jun, Ki‐Bum Won, et al.. (2023). Association of Clinical Outcomes With Sex in Patients Receiving Chronic Maintenance Antiplatelet Monotherapy After Percutaneous Coronary Intervention: A Post Hoc Gender Analysis of the HOST‐EXAM Study. Journal of the American Heart Association. 12(8). e026770–e026770. 2 indexed citations

Kang, Jeehoon, Kyu‐Sun Lee, Hak Seung Lee, et al.. (2023). Differential Effect of Left Ventricular Unloading According to the Aetiology of Cardiogenic Shock. ESC Heart Failure. 11(1). 338–348. 8 indexed citations

Kang, Jeehoon, Kyung Woo Park, H. K. Lee, et al.. (2022). Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study. Circulation. 147(2). 108–117. 63 indexed citations

Kang, Jeehoon, Kyung Woo Park, Doyeon Hwang, et al.. (2022). TCT-22 Clopidogrel Versus Aspirin in the Chronic Maintenance Period Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Subgroup Analysis of the HOST-EXAM Trial. Journal of the American College of Cardiology. 80(12). B9–B9. 1 indexed citations

Kwon, Yoo‐Wook, Jin Woo Lee, Han‐Mo Yang, et al.. (2021). HLA DR Genome Editing with TALENs in Human iPSCs Produced Immune-Tolerant Dendritic Cells. Stem Cells International. 2021. 1–14. 17 indexed citations

10.

Rhee, Tae‐Min, Joo Myung Lee, Eun‐Seok Shin, et al.. (2018). Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis. JACC: Cardiovascular Interventions. 11(10). 969–978. 37 indexed citations

11.

Kim, Chihoon, Jung‐Kyu Han, Han‐Mo Yang, et al.. (2017). Study protocol for a randomised controlled trial: harmonising optimal strategy for treatment of coronary artery stenosis — coronary intervention with next-generation drug-eluting stent platforms and abbreviated dual antiplatelet therapy (HOST-IDEA) trial. BMJ Open. 7(10). e016617–e016617. 4 indexed citations

12.

Lee, Joo Myung, Jeehoon Kang, Euijae Lee, et al.. (2016). Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era. JACC: Cardiovascular Interventions. 9(20). 2097–2109. 50 indexed citations

13.

Lee, Joo Myung, Jonghanne Park, Jeehoon Kang, et al.. (2015). Comparison Among Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for the Treatment of In-Stent Restenosis. JACC: Cardiovascular Interventions. 8(3). 382–394. 84 indexed citations

14.

Lee, Joo Myung, Jonghanne Park, Ki‐Hyun Jeon, et al.. (2014). Efficacy of Short-Term High-Dose Statin Pretreatment in Prevention of Contrast-Induced Acute Kidney Injury: Updated Study-Level Meta-Analysis of 13 Randomized Controlled Trials. PLoS ONE. 9(11). e111397–e111397. 21 indexed citations

15.

Lee, Sahmin, Hyun-Chae Lee, Yoo‐Wook Kwon, et al.. (2014). Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human Monocytes. Cell Metabolism. 19(3). 484–497. 212 indexed citations

16.

Yang, Han‐Mo, Ju‐Young Kim, Yoo‐Wook Kwon, et al.. (2013). PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury. Experimental & Molecular Medicine. 45(11). e65–e65. 35 indexed citations

17.

Lee, Sang Eun, Yong‐Jin Kim, Hae‐Young Lee, et al.. (2012). Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension. Clinical Therapeutics. 34(3). 552–568.e9. 46 indexed citations

18.

Park, Kyung Woo, Joo Myung Lee, Si‐Hyuck Kang, et al.. (2012). Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice. Journal of the American College of Cardiology. 61(5). 536–544. 38 indexed citations

19.

Kim, Ju‐Young, Hyun‐Jai Cho, Jin Hur, et al.. (2009). Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia. Cardiovascular Research. 82(3). 550–560. 45 indexed citations

20.

Yang, Han‐Mo. (2001). Current Status and Recent Issues in Domestic Air Space Management System. 14. 207–240.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact